M. Renninger

2.5k total citations
64 papers, 980 citations indexed

About

M. Renninger is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Renninger has authored 64 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 11 papers in Urology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Renninger's work include Bladder and Urothelial Cancer Treatments (20 papers), Urological Disorders and Treatments (11 papers) and Urinary and Genital Oncology Studies (11 papers). M. Renninger is often cited by papers focused on Bladder and Urothelial Cancer Treatments (20 papers), Urological Disorders and Treatments (11 papers) and Urinary and Genital Oncology Studies (11 papers). M. Renninger collaborates with scholars based in Germany, Malaysia and United States. M. Renninger's co-authors include Arnulf Stenzl, Georgios Gakis, Tina Schubert, Tilman Todenhöfer, Christian Schwentner, Omar Fahmy, Mohd Ghani Khairul‐Asri, Hubert Kübler, Karl‐Dietrich Sievert and David Schilling and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Advanced Drug Delivery Reviews.

In The Last Decade

M. Renninger

59 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Renninger Germany 19 406 175 172 161 152 64 980
B. B. Goldberg United States 21 315 0.8× 68 0.4× 786 4.6× 46 0.3× 245 1.6× 66 1.8k
R. Faccini Italy 18 112 0.3× 83 0.5× 61 0.4× 37 0.2× 164 1.1× 70 961
David P. Taylor United States 18 185 0.5× 219 1.3× 192 1.1× 23 0.1× 150 1.0× 74 1.2k
W. Waidelich Germany 18 161 0.4× 61 0.3× 194 1.1× 28 0.2× 35 0.2× 100 1.1k
James R. Oleson United States 30 215 0.5× 165 0.9× 60 0.3× 12 0.1× 402 2.6× 90 3.2k
Maximilian Schmid Austria 29 874 2.2× 239 1.4× 252 1.5× 9 0.1× 309 2.0× 98 2.6k
B Holmström Sweden 18 251 0.6× 198 1.1× 71 0.4× 10 0.1× 282 1.9× 52 935
Ken Ando Japan 18 218 0.5× 275 1.6× 90 0.5× 5 0.0× 276 1.8× 80 1.1k
Dennis A. Chakkalakal United States 17 227 0.6× 85 0.5× 105 0.6× 29 0.2× 20 0.1× 32 1.0k
Peter L. Roberson United States 26 109 0.3× 89 0.5× 132 0.8× 48 0.3× 843 5.5× 66 2.0k

Countries citing papers authored by M. Renninger

Since Specialization
Citations

This map shows the geographic impact of M. Renninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Renninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Renninger more than expected).

Fields of papers citing papers by M. Renninger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Renninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Renninger. The network helps show where M. Renninger may publish in the future.

Co-authorship network of co-authors of M. Renninger

This figure shows the co-authorship network connecting the top 25 collaborators of M. Renninger. A scholar is included among the top collaborators of M. Renninger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Renninger. M. Renninger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asimakopoulos, Anastasios D., Omar Fahmy, Fahmy A. S. Hassan, et al.. (2023). New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer. Bladder Cancer. 9(3). 237–251. 2 indexed citations
2.
Gakis, Georgios, et al.. (2022). The Predictive and Prognostic Value of Precystectomy Serum Gamma-Glutamyltransferase Levels in Patients With Invasive Bladder Cancer. Clinical Genitourinary Cancer. 20(4). e310–e316. 2 indexed citations
3.
Gakis, Georgios, Sven Perner, Arnulf Stenzl, & M. Renninger. (2022). The CAG-triplet in the androgen receptor gene and single-nucleotide polymorphisms in androgen pathway genes in patients with concomitant bladder and prostate cancer. Urologic Oncology Seminars and Original Investigations. 40(5). 198.e1–198.e8. 2 indexed citations
4.
Fahmy, Omar, Mohd Ghani Khairul‐Asri, Tina Schubert, et al.. (2017). Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 36(2). 54–59. 27 indexed citations
5.
Fahmy, Omar, Mohd Ghani Khairul‐Asri, Tina Schubert, et al.. (2017). A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 36(2). 43–53. 114 indexed citations
6.
Gakis, Georgios, Michael Rink, Hans‐Martin Fritsche, et al.. (2016). Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer. Urologia Internationalis. 97(1). 42–48. 8 indexed citations
7.
Gakis, Georgios, Steffen Rausch, Johannes Mischinger, et al.. (2015). Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy. World Journal of Urology. 33(10). 1429–1437. 27 indexed citations
8.
Schubert, Tina, Tilman Todenhöfer, Johannes Mischinger, et al.. (2015). The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer. World Journal of Urology. 34(6). 829–834. 15 indexed citations
9.
Tsaur, Igor, M. Renninger, Joerg Hennenlotter, et al.. (2013). Reliable housekeeping gene combination for quantitative PCR of lymph nodes in patients with prostate cancer.. PubMed. 33(12). 5243–8. 16 indexed citations
10.
Todenhöfer, Tilman, M. Renninger, Christian Schwentner, Arnulf Stenzl, & Georgios Gakis. (2012). A new prognostic model for cancer‐specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. British Journal of Urology. 110(11b). E533–40. 46 indexed citations
11.
Gakis, Georgios, Arnulf Stenzl, & M. Renninger. (2012). Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy?. Scandinavian Journal of Urology. 47(5). 358–362. 10 indexed citations
12.
Vaegler, Martin, Andrew T. Lenis, Bastian Amend, et al.. (2012). Stem cell therapy for voiding and erectile dysfunction. Nature Reviews Urology. 9(8). 435–447. 26 indexed citations
13.
Gakis, Georgios, Tilman Todenhöfer, M. Renninger, et al.. (2011). Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C‐reactive protein and standard pathological risk factors: the TNR‐C score. British Journal of Urology. 108(11). 1800–1805. 80 indexed citations
14.
Gakis, Georgios, David Schilling, M. Renninger, et al.. (2010). Comparison of the new American Joint Committee on Cancer substratification in node‐negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series. British Journal of Urology. 107(6). 919–923. 13 indexed citations
15.
Feil, Gerhard, Bastian Amend, Sabine Maurer, et al.. (2010). From tissue engineering to regenerative medicine in urology — The potential and the pitfalls. Advanced Drug Delivery Reviews. 63(4-5). 375–378. 13 indexed citations
16.
Amend, Bastian, et al.. (2009). Rekonstruktive Urologie des oberen und unteren Harntraktes - ein Therapieupdate. Journal für Kardiologie (Krause & Pachernegg GmbH). 16(1). 7–14. 1 indexed citations
17.
Sievert, K.D., Bastian Amend, M. Renninger, et al.. (2007). Stellenwert der Stammzelltherapie für die Behandlung der Belastungsinkontinenz. Der Urologe. 46(3). 264–267. 2 indexed citations
18.
Feil, Gerhard, M. Renninger, S. Conrad, et al.. (2007). „Tissue engineering“ und Stammzellforschung in der Urologie für den rekonstruktiven bzw. regenerativen Therapieansatz. Der Urologe. 46(9). 1224–1230. 4 indexed citations
19.
Herrlinger, Ulrich, et al.. (2004). Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value. British Journal of Cancer. 91(2). 219–224. 58 indexed citations
20.
Renninger, M.. (1955). Beitrag zur Kenntnis der röntgenographischen Unterschiede zwischen den beiden Diamant-Typen. Acta Crystallographica. 8(10). 606–610. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. B. Goldberg Breakdown of academic impact, for papers by R. Faccini Breakdown of academic impact, for papers by David P. Taylor Breakdown of academic impact, for papers by W. Waidelich Breakdown of academic impact, for papers by James R. Oleson Breakdown of academic impact, for papers by Maximilian Schmid Breakdown of academic impact, for papers by B Holmström Breakdown of academic impact, for papers by Ken Ando Breakdown of academic impact, for papers by Dennis A. Chakkalakal Breakdown of academic impact, for papers by Peter L. Roberson
Rankless by CCL
2026